Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
Factor IX, Quantity: 50 IU/mL
CSL Behring Australia Pty Ltd
Factor IX
Injection, diluent for
Excipient Ingredients: water for injections
Intravenous
500 IU
Medicine Listed (Export Only)
Not scheduled. Not considered by committee
"TBSF" High Purity Factor IX Concentrate is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia B. "TBSF" High Purity Factor IX Concentrate is not indicated for the treatment of factor II, VII or X deficiencies because it does not contain therapeutic levels of these coagulation factors. "TBSF" High Purity Factor IX Concentrate is not indicated for the treatment of haemophilia A patients with factor VIII inhibitors.
Visual Identification: Clear, colourless solution free from visible particles; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2006-03-01